Short Sellers Were Right About These 5 Stocks

4. Cassava Sciences, Inc. (NASDAQ:SAVA)

Number of Hedge Fund Holders: 7 

Float Shorted: 37%

Decline in Share Price Over Past Six Months: 67%     

Cassava Sciences, Inc. (NASDAQ:SAVA) is a clinical-stage biotech firm. The stock has been hit in recent months after allegations that the company manipulated trial results of an Alzheimer’s drug named simufilam. The firm was involved in an SEC probe as well. 

Top hedge funds continue to hold large stakes in Cassava Sciences, Inc. (NASDAQ:SAVA). Among the hedge funds being tracked by Insider Monkey, Chicago-based investment firm Citadel Investment Group is a leading shareholder in Cassava Sciences, Inc. (NASDAQ:SAVA) with 1 million shares worth more than $46 million.